Biovance Capital invests in early-stage biopharma companies developing new therapeutics across Europe, with a focus in Portugal, Spain and Italy.

Biovance Capital Partners is a venture capital firm based in Lisbon that manages Biovance Capital Fund I. This is a biotech-focused fund up to €60M backed by the European Investment Fund and other public and private investors.

• We have a strong team with deep expertise in VC, biotech and pharma. Our team includes PhD and MDs and an inventor of medical products, all educated at leading institutions such as Harvard University, MIT and Imperial College.
• Most of our team members have been full-time VCs for the past 9 years, having successfully invested in health startups in the UK, Spain and Portugal.
• We invest in Europe, looking for opportunities in academia, biotech, and pharmaceutical companies.
• We collaborate with exceptional entrepreneurs and provide capital, expertise, and access to a global network of resources to add value.
• We have privileged access to high-quality deal flow from leading universities, incubators and accelerators in Europe, enabling us to invest in breakthrough medical treatments that can generate profitable returns.
• Before investing in a company, we perform a rigorous and extensive due diligence and help entrepreneurs improve their product development roadmap.
• We have a wide personal network of international VCs.